References
- SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
- TaylorJAIIIKuchelGABladder cancer in the elderly: clinical outcomes, basic mechanisms, and future research directionNat Clin Pract Urol20096313514419265855
- ChromeckiTFBensalahKRemziMPrognostic factors for upper urinary tract urothelial carcinomaNat Rev Urol20118844044721727942
- DanglePPZaharievaBJiaHPoharKSRas-MAPK pathway as a therapeutic target in cancer – emphasis on bladder cancerRecent Pat Anticancer Drug Discov20094212513619519535
- GerhardtDBertolaGDietrichFBoldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3betaUrol Oncol201432136.e19
- ZhengXOuYShuMCholera toxin, a typical protein kinase A activator, induces G1 phase growth arrest in human bladder transitional cell carcinoma cells via inhibiting the c-Raf/MEK/ERK signaling pathwayMol Med Rep2014951773177924626525
- VivancoISawyersCLThe phosphatidylinositol 3-kinase AKT pathway in human cancerNat Rev Cancer20022748950112094235
- LeeMHYangHYNegative regulators of cyclin-dependent kinases and their roles in cancersCell Mol Life Sci20015812–131907192211766887
- LiABlowJJThe origin of CDK regulationNat Cell Biol200138E182E18411483974
- ZetterbergALarssonOWimanKGWhat is the restriction point?Curr Opin Cell Biol1995768358428608014
- CanaveseMSantoLRajeNCyclin dependent kinases in cancer: potential for therapeutic interventionCancer Biol Ther201213745145722361734
- PaternotSBockstaeleLBisteauXKookenHCoulonvalKRogerPPRb inactivation in cell cycle and cancer: the puzzle of highly regulated activating phosphorylation of CDK4 versus constitutively active CDK-activating kinaseCell Cycle20109468969920107323
- HarperJWAdamiGRWeiNKeyomarsiKElledgeSJThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinasesCell19937548058168242751
- HarperJWElledgeSJKeyomarsiKInhibition of cyclin-dependent kinases by p21Mol Biol Cell1995643874007626805
- BiancoFJJrGervasiDCTiguertRMatrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and gradeClin Cancer Res1998412301130169865914
- DaviesBWaxmanJWasanHLevels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasionCancer Res19935322536553698221672
- ZhouYTHeWWamerWGEnzyme-mimetic effects of gold@platinum nanorods on the antioxidant activity of ascorbic acidNanoscale2013541583159123329011
- FanJYinJJNingBDirect evidence for catalase and peroxidase activities of ferritin-platinum nanoparticlesBiomaterials20113261611161821112084
- LeeJYoonSLoMWuHSYLMoonBIntrinsic polyphenol oxidase-like activity of gold@platinum nanoparticlesRSC Adv201556375763764
- KimJTakahashiMShimizuTEffects of a potent antioxidant, platinum nanoparticle, on the lifespan of Caenorhabditis elegansMech Ageing Dev2008129632233118400258
- WatanabeAKajitaMKimJIn vitro free radical scavenging activity of platinum nanoparticlesNanotechnology2009204545510519834242
- LeeJSonJYooKLoMMoonBCharacterization of the antioxidant activity of gold@platinum nanoparticlesRSC Adv201441982419830
- MateoDMoralesPAvalosAHazaAIOxidative stress contributes to gold nanoparticle-induced cytotoxicity in human tumor cellsToxicol Mech Methods201424316117224274460
- BhamidipatiMFabrisLMultiparametric assessment of gold nanoparticle cytotoxicity in cancerous and healthy cells: the role of size, shape, and surface chemistryBioconjug Chem201728244946027992181
- ChoSKEmotoKSuLJYangXFlaigTWParkWFunctionalized gold nanorods for thermal ablation treatment of bladder cancerJ Biomed Nanotechnol20141071267127624804547
- HsiehDSWangHTanSWThe treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticlesBiomaterials201132307633764021782236
- GehrkeHPelkaJHartingerCGPlatinum nanoparticles and their cellular uptake and DNA platination at non-cytotoxic concentrationsArch Toxicol201185779981221229235
- PelkaJGehrkeHEsselenMCellular uptake of platinum nanoparticles in human colon carcinoma cells and their impact on cellular redox systems and DNA integrityChem Res Toxicol200922464965919290672
- PorcelELiehnSRemitaHPlatinum nanoparticles: a promising material for future cancer therapy?Nanotechnology20102188510320101074
- YueYWagnerSMedina-KauweLWE-FG-BRA-11: theranostic platinum nanoparticle for radiation sensitization in breast cancer radiotherapyMed Phys20164363826
- ShmarakovIMukhaIVityukNAntitumor activity of alloy and core-shell-type bimetallic AgAu nanoparticlesNanoscale Res Lett201712133328476089
- WenzelMBertrandBEyminMJMultinuclear cytotoxic metallodrugs: physicochemical characterization and biological properties of novel heteronuclear gold-titanium complexesInorg Chem201150199472948021875041
- DanoKRomerJNielsenBSCancer invasion and tissue remodeling – cooperation of protease systems and cell typesAPMIS1999107112012710190288
- SahaSXiongXChakrabortyPKGold nanoparticle reprograms pancreatic tumor microenvironment and inhibits tumor growthACS Nano20161012106361065127758098
- QuYLuXAqueous synthesis of gold nanoparticles and their cytotoxicity in human dermal fibroblasts-fetalBiomed Mater20094202500719258699
- LvDWuHXingRHnRNP-L mediates bladder cancer progression by inhibiting apoptotic signaling and enhancing MAPK signaling pathwaysOncotarget201788135861359928088793
- QiuLZhouCSunYPaclitaxel and ceramide synergistically induce cell death with transient activation of EGFR and ERK pathway in pancreatic cancer cellsOncol Rep200616490791316969513
- Fernandez-GallardoJElieBTSadhukhaTHeterometallic titanium-gold complexes inhibit renal cancer cells in vitro and in vivoChem Sci2015695269528327213034
- ArvizoRRSahaSWangERobertsonJDBhattacharyaRMukherjeePInhibition of tumor growth and metastasis by a self-therapeutic nanoparticleProc Natl Acad Sci U S A2013110176700670523569259
- WangXBGaoHYHouBLHuangJXiRGWuLJNanoparticle realgar powders induce apoptosis in U937 cells through caspase MAPK and mitochondrial pathwaysArch Pharm Res200730565365817615687
- LeeEJLeeSJKimSInterleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-kappaB/AP-1 pathway: involvement of the p21WAF1 expressionCell Signal201325102025203823770289